Get Live Data

If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Genedrive Share Price
  4. Genedrive Share Regulatory News
  5. Notice of AGM

Pin to quick picksGenedrive Regulatory News (GDR)

Genedrive Information

Share Price Information for Genedrive (GDR)

Share Price is delayed by 15 minutes
Get Live Data
1.30    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.10 (8.00%)
Market Cap: £20.87m
GDR Live PriceLast checked at - London Stock Exchange

Intraday Genedrive Share Chart

Notice of AGM

5 Dec 2022 07:00

RNS Number : 4815I
Genedrive PLC
05 December 2022
Ā 

Ā 

Ā 

genedrive plc

("genedrive" or the "Company")

Ā 

Annual Report and Accounts and date of AGM

Ā 

genedrive plc (AIM: GDR),Ā the near patient molecular diagnostics company, announces that its 2022 Annual Report and Accounts are now available on the Company's website http://www.genedriveplc.com/investor-relations/company-reports.php.Ā  The Notice of the 2022 Annual General Meeting ("AGM") and hard copies of the 2022 Annual Report and Accounts will be posted to shareholders on or around 5 December 2022.

Ā 

The Company's AGM will be held at 11am on 29 December 2022 at 46 Grafton Street, Manchester M13 9XX.

Ā 

Ā 

For further details please contact:

Ā 

genedrive plc

+44 (0)161 989 0245

David Budd: CEO /Ā Russ Shaw: CFO

Peel Hunt LLPĀ (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

James Steel / Oliver Duckworth

finnCap (Joint Broker)

+44 (0)20 7220 500

Geoff Nash / George Dollemore / Nigel Birks / Alice Lane

Walbrook PR LtdĀ (Media Relations & Investor Relations)

+44 (0)20 7933 8780 orĀ genedrive@walbrookpr.com

Paul McManusĀ /Ā Anna Dunphy

+44 (0)7980 541 893 / +44 (0)7876 741 001

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
NOABXBDDCDGDGDD
12345678910
Date   Source Headline
1st Jul 20267:00 amRNSBoard change
29th Jun 20267:00 amRNSCYP2C19 Agreement with Thermo Fisher Scientific
18th Jun 20267:00 amRNSManchester NHS Trust transitions MT-RNR1 to BAU
5th Jun 20267:00 amRNSReceipt of R&D tax credit
1st Jun 20267:00 amRNSBlock Listing Returns
26th May 20267:00 amRNSBoard Changes
6th May 202611:56 amRNSHolding(s) in Company
5th May 20267:00 amRNSSussex NHS Trust transitions MT-RNR1 test to BAU
21st Apr 20267:00 amRNSNHS England commercial strategy for MT-RNR1
20th Apr 20267:00 amRNS-RInteractive Investor Hub Updates
16th Apr 20267:00 amRNSCYP2C19 kit implemented in North Bristol NHS Trust
30th Mar 20267:00 amRNSInterim Results to 31 December 2025
12th Mar 20269:52 amRNSHolding(s) in Company
12th Mar 20267:00 amRNSHolding(s) in Company
12th Mar 20267:00 amRNSHolding(s) in Company
11th Mar 20263:22 pmRNSHolding(s) in Company
11th Mar 20263:22 pmRNSHolding(s) in Company
9th Mar 202611:29 amRNSResult of General Meeting
9th Mar 20267:00 amRNSResult of Open Offer and Additional Subscriptions
24th Feb 20262:32 pmRNSHolding(s) in Company
24th Feb 202612:05 pmRNSHolding(s) in Company
19th Feb 20267:00 amRNSPublication of circular, notice of GM & timetable
13th Feb 20264:22 pmRNSCompletion of Placing
13th Feb 20262:04 pmRNSProposed Direct Subscription to raise up to £3.5m
6th Feb 20269:50 amRNSHolding(s) in Company
3rd Feb 202610:59 amRNSHolding(s) in Company
27th Jan 20262:18 pmRNSHolding(s) in Company
19th Jan 20263:01 pmRNSProposed equity raise of up to £6.0 million
31st Dec 202511:44 amRNSResult of AGM
31st Dec 202511:44 amRNSResult of AGM
18th Dec 20257:00 amRNSScotland NHS “test of change” pilot programme
11th Dec 20259:00 amRNSNew interactive investor hub
9th Dec 20253:45 pmRNSAgreement of Shareholder Loan
8th Dec 20254:00 pmRNSAnnual Report and Accounts and date of AGM
5th Dec 20257:00 amRNSFinal Results
3rd Dec 20257:00 amRNSNotice of Results
1st Dec 20253:19 pmRNSBlock Listing Returns
1st Dec 20257:00 amRNSResults presented re. NHS CYP2C19 Genotype Testing
27th Nov 202510:09 amRNSNHS implementation guide published for CYP2C19
26th Nov 20257:00 amRNSScotland national roll-out of MT-RNR1 ID Kit
19th Nov 20257:00 amRNSFurther re Shareholder Loan
4th Nov 20257:00 amRNSMT-RNR1 ID Kit in Dublin’s Rotunda Hospital
31st Oct 20257:00 amRNSPotential Shareholder Loan
29th Oct 20254:35 pmRNSHolding(s) in Company
28th Oct 20257:00 amRNSMOU with Kingdom of Saudi Arabia for MT-RNR1 ID
24th Oct 20254:30 pmRNSApplication for Listing & Total Voting Rights
15th Oct 202510:49 amRNSResult of General Meeting
10th Oct 20251:32 pmRNSHolding(s) in Company
10th Oct 20251:31 pmRNSHolding(s) in Company
10th Oct 20259:00 amRNSHolding(s) in Company
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
IGG
IG
LSE
0.00%
MKS
Marks & Spencer
LSE
0.00%
JSG
Johnson Service
LSE
0.00%
BXP
Beximco Pharma
LSE
0.00%
ELM
Elementis
LSE
0.00%
Trending
GGP
Greatland Resources
LSE
0.00%
ITV
ITV
LSE
0.00%
RCGH
Rc365 Holding
LSE
0.00%
LLOY
Lloyds
LSE
0.00%
AMG
Atlas Metals Group PLC
LSE
0.00%